文献速递妇科

低危非转移性妊娠滋养细胞肿瘤且不再希望生育女性的首选子宫切除术

First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive.
PubMed 文献 · Gynecol Oncol · 2018-06-08

在法国中心1072例低危妊娠滋养细胞肿瘤患者中,74例接受首选子宫切除术,其中61例(82.4%,95%CI 71.8-90.3)术后hCG正常化且无需挽救化疗;FIGO评分5-6分和绒毛膜癌与需挽救化疗风险相关。作者认为在生育需求已满足时可作为单药化疗的替代选择,但年轻患者不应考虑此方案。

要点

  • 首选子宫切除术后82.4%(61/74)患者hCG正常化且无需挽救化疗。
  • FIGO评分5-6分(OR 8.961,95%CI 1.60-64.96)与需挽救化疗风险相关。
  • 绒毛膜癌(OR 14.295,95%CI 1.78-138.13)与需挽救化疗风险相关。

核心结论

  • 首选子宫切除术对低危非转移性妊娠滋养细胞肿瘤有效,82.4%女性无需挽救化疗即可hCG正常化。
  • 当生育考虑已满足时,子宫切除术可作为单药化疗的替代选择。
  • 年轻患者不应考虑此治疗选择,因为单药化疗在近100%患者中可治愈并保留生育功能。

研究设计与样本

  • 回顾性比较研究,法国中心1072例低危妊娠滋养细胞肿瘤患者中74例接受首选子宫切除术。
  • 将首选子宫切除术成功患者与需进一步挽救化疗患者进行回顾性比较。

主要发现

  • 首选子宫切除术后61例(82.4%,95%CI 71.8-90.3)hCG正常化且无需挽救化疗,13例需挽救化疗。
  • 多因素分析显示FIGO评分5-6分与需挽救化疗风险相关(精确OR 8.961,95%CI 1.60-64.96)。
  • 绒毛膜癌的存在与需挽救化疗风险相关(精确OR 14.295,95%CI 1.78-138.13)。

临床怎么用

  • 作者认为,当生育考虑已满足时,子宫切除术可作为低危非转移性妊娠滋养细胞肿瘤单药化疗的替代选择。
  • 作者认为,年轻患者不应考虑首选子宫切除术,因为单药化疗在近100%患者中可治愈并保留生育功能。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low-risk gestational trophoblastic neoplasia (GTN) patients (FIGO score ≤6) are generally treated with single agent chemotherapy (methotrexate or dactinomycin) resulting in a 5-year mortality rate of 0.3%. However, despite these encouraging survival rates, chemotherapy is associated with significant adverse events in most patients. Although it is generally accepted that patients who no longer wish to conceive may be treated by hysterectomy for a hydatidiform mole, the evidence to support this strategy in low-risk GTN patients is lacking. OBJECTIVES: To describe the survival, efficacy, and tolerance associated with first-line hysterectomy in low-risk non-metastatic GTN patients. STUDY DESIGN: Seventy-four of 1072 low-risk GTN patients treated in the French Center underwent first-line hysterectomy. Patients data with successful first-line hysterectomy were retrospectively compared to those requiring further salvage chemotherapy. RESULTS: First-line hysterectomy was followed by hCG normalization in 61 patients (82.4%, 95% confidence interval [CI] 71.8-90.3) without any further salvage chemotherapy, whereas 13 patients required salvage chemotherapy. After multivariate analysis, a FIGO score of 5-6 (exact OR 8.961, 95%CI 1.60-64.96), and the presence of choriocarcinoma (exact OR 14.295, 95%CI 1.78-138.13) were associated with the risk of requiring salvage chemotherapy. CONCLUSION: Hysterectomy as a first-line treatment is effective without salvage chemotherapy in 82.4% of women with low-risk non-metastatic GTN and can be presented as an alternative to single-agent chemotherapy when childbearing considerations have been fulfilled. In young patients, this therapeutic option should not be considered because single-agent chemotherapies are curative in nearly 100% of patients while maintaining fertility.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bolze PA, Mathe M, Hajri T, et al. First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive. Gynecol Oncol. 2018. PMID: 29887485. doi:10.1016/j.ygyno.2018.05.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。